Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects

Clinical trial NCT07175220 · RECRUITING

Trial details

NCT number: NCT07175220
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Non-small Cell Lung Cancer

Start date: 2025-10-09
Primary completion: 2028-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.